RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2025 /PRNewswire/ -- Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development plans for its lead assets, DTI-117 and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference )
Also on site :
- EU state pledges funds to help aspirant counter ‘Russian threats’
- Food Network star Anne Burrell dies aged 55 leaving Worst Cooks in America fans devastated after show absence
- Downtown Lincolnton on lockdown after 'credible threat,' police say no active shooter